Author: Fan, Li; Le, Wenqing; Zou, Qin; Zhou, Xiuxiu; Wang, Yun; Tang, Hao; Han, Jiafa; Liu, Shiyuan
Title: Initial CT features of COVID-19 predicting clinical category Cord-id: eqme100i Document date: 2021_2_21
ID: eqme100i
Snippet: PURPOSE: To analyze the initial CT features of different clinical categories of COVID-19. MATERIAL AND METHODS: A total of 86 patients with COVID-19 were analyzed, including the clinical, laboratory and imaging features. The following imaging features were analyzed, the lesion amount, location, density, lung nodule, halo sign, reversed-halo sign, distribution pattern, inner structures and changes of adjacent structures. Chi-square test, Fisher’s exact test, or Mann–Whitney U test was used fo
Document: PURPOSE: To analyze the initial CT features of different clinical categories of COVID-19. MATERIAL AND METHODS: A total of 86 patients with COVID-19 were analyzed, including the clinical, laboratory and imaging features. The following imaging features were analyzed, the lesion amount, location, density, lung nodule, halo sign, reversed-halo sign, distribution pattern, inner structures and changes of adjacent structures. Chi-square test, Fisher’s exact test, or Mann–Whitney U test was used for the enumeration data. Binary logistic regression analysis was performed to draw a regression equation to estimate the likelihood of severe and critical category. The forward conditional method was employed for variable selection. RESULTS: Significant statistical differences were found in age (p = 0.001) and sex (p = 0.028) between mild and moderate and severe and critical category. No significant difference was found in clinical symptoms and WBC count between the two groups. The majority of cases (91.8%) showed multifocal lesions. The presence of GGO was higher in severe and critical category than in the mild and moderate category. (57.8% vs.31.7%, p = 0.015). Lymphocyte count was important indicator for the severe and critical category. CONCLUSION: The initial CT features of the different clinical category overlapped. Combining with laboratory test, especially the lymphocyte count, could help to predict the severity of COVID-19. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s42058-021-00056-4.
Search related documents:
Co phrase search for related documents- lobe location and lymphadenopathy pleural effusion: 1, 2
- logistic regression analysis and lymphadenopathy pleural effusion: 1
- logistic regression analysis and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- logistic regression analysis and lymphocyte count decrease: 1, 2, 3
- logistic regression analysis and lymphocyte count low: 1, 2, 3, 4, 5, 6, 7
- logistic regression analysis and lymphocyte count wbc: 1, 2, 3, 4, 5, 6, 7, 8
- logistic regression and lung nodule: 1
- logistic regression and lymphadenopathy pleural effusion: 1, 2, 3
- logistic regression and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- logistic regression and lymphocyte count decrease: 1, 2, 3
- logistic regression and lymphocyte count low: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- logistic regression and lymphocyte count wbc: 1, 2, 3, 4, 5, 6, 7, 8, 9
- lung nodule and lymphadenopathy pleural effusion: 1
Co phrase search for related documents, hyperlinks ordered by date